← Open Payments lookup

KALPESH BHAVSAR: Open Payments

NPI 1457546913 · ROSEMEAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,402 in 54 payments from 10 companies in 2025. Trend: 2023 $1,431 · 2024 $1,412 · 2025 $1,402

Food & beverage: $1,402
CompanyPaymentsAmount
Axsome Therapeutics, Inc.8$268
Otsuka America Pharmaceutical, Inc.11$262
ABBVIE INC.10$216
Alkermes, Inc.5$148
Vanda Pharmaceuticals Inc.5$146
E.R. Squibb & Sons, L.L.C.5$128
Almatica Pharma LLC5$112
Janssen Pharmaceuticals, Inc3$68
Teva Pharmaceuticals USA, Inc.1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26

Products named: Auvelity, VRAYLAR, ABILIFY ASIMTUFII, ARISTADA, HETLIOZ, COBENFY, LOREEV XR, REXULTI.

Industry payments across CA — which companies pay providers there.